Discover the future of creativity with award winning creatives and experts at International Seminar of Creativity
Pfizer discontinues global Phase III Trial of axitinib for futility in advanced pancreatic cancerMagna Carta 3 Feb 2009
Sunitinib is cost effective as a first-line therapy for patients with metastatic renal celMagna Carta 23 Sep 2008
Avastin the only biologic to show overall survival benefit in some patients with colorectal cancerThe Mail Room 17 Sep 2008
Pfizer discontinues global Phase III Trial of axitinib for futility in advanced pancreatic cancerMagna Carta 3 Feb 2009
Sunitinib is cost effective as a first-line therapy for patients with metastatic renal celMagna Carta 23 Sep 2008
Avastin the only biologic to show overall survival benefit in some patients with colorectal cancerThe Mail Room 17 Sep 2008